February 17, 2021
SALT LAKE CITY–(BUSINESS WIRE)–Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market release of Kore Fiber™, an exclusively processed demineralized cortical fiber allograft for Kolosis.
Dr. Anthony Russo, the first surgeon nationwide to implant Kore and incorporate the tissue into his practice, said, “The aseptic processing methods coupled with the favorable handling characteristics of Kore provide an excellent option for bone grafting. I have used MTF allografts extensively over 20 years, in both general orthopedic cases as well as spine surgery cases. I am a believer that MTF allografts help accelerate bone formation for my patients with less risk than available alternatives, including autograft harvest.” Dr. Russo is a partner at Montana Orthopedics in Butte, Montana.
Kolosis Chief Executive Officer Collin Begley noted, “We are extremely excited to launch Kore Fiber with MTF Biologics. Based on our commercial experience in bone grafting technologies, especially with MTF processed tissues, we see the enormous potential of this tissue-form to capture significant market share in the cortical fiber space. Kore is an aseptically-processed, 100% cortical bone matrix with tremendous handling characteristics. Extensive pre-launch testing confirms Kore’s dynamic spectrum of growth factors; attributes which are essential for promoting and accelerating bone healing. We could not be more excited to add Kore Fiber to our exclusive MTF portfolio of bone graft tissues.”
Kore Fiber is available in four different sizes of moldable fiber and three sizes of strips.
About Kolosis BIO, LLC:
Kolosis BIO is a pure-play orthobiologics company focused on commercializing Bold Technologies with Relentless Execution.
Kolosis exclusively partners with MTF to deliver market-leading bone graft technologies in the orthopedic space. The company’s initial tissue offering, Prime HD, is exclusively represented by Kolosis through its network of independent distributor partners. Prime HD is a pre-hydrated cortical matrix offering superior quality through MTF’s proprietary aseptic processing methods and features outstanding handling characteristics and convenient delivery, making the graft ideal for a variety of challenging clinical applications, especially where cost is a primary consideration. The addition of Kore Fiber further establishes Kolosis as a notable player in the orthobiologics space. The company continues to evolve and expand its portfolio of scientifically superior bone grafts while delivering distributor-centric solutions with relentless service and support. For more information visit www.kolosis.com.
About MTF Biologics:
MTF Biologics is a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research. We provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of life, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists. Our subsidiary, The International Institute for the Advancement of Medicine (IIAM), honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Our subsidiary, Statline, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Our sister organization, The German Institute for Cell and Tissue Transplantation (Deutsches Institute for Zell-und Gewebeersatz – DIZG) expands our reach to patients across the globe. For more information, visit www.mtfbiologics.org.